These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3488022)

  • 1. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Elwell LP; Wilson HR; Knick VB; Keith BR
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1092-4. PubMed ID: 3488022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.
    de Górgolas M; Avilés P; Verdejo C; Fernández Guerrero ML
    Antimicrob Agents Chemother; 1995 Apr; 39(4):953-7. PubMed ID: 7786002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
    Unowsky J; Chandrasekar PH; DeLorenzo W; Levine DP
    Chemotherapy; 1986; 32(6):499-505. PubMed ID: 3492342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin].
    Bismuth R; Jarlier V; Grosset J
    Pathol Biol (Paris); 1983 May; 31(5):429-33. PubMed ID: 6353335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
    Crider SR; Colby SD
    Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
    Grim SA; Rapp RP; Martin CA; Evans ME
    Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections.
    Ellison RT; Judson FN; Peterson LC; Cohn DL; Ehret JM
    West J Med; 1984 May; 140(5):735-40. PubMed ID: 6610253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.
    Yeldandi V; Strodtman R; Lentino JR
    J Antimicrob Chemother; 1988 Dec; 22(6):873-80. PubMed ID: 3266621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
    Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
    Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decade of antimicrobial resistance in Staphylococcus aureus: A single center experience.
    Vicetti Miguel CP; Mejias A; Leber A; Sanchez PJ
    PLoS One; 2019; 14(2):e0212029. PubMed ID: 30753206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
    Arnold FW; Wojda B
    J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to sulfamethoxazole and trimethoprim.
    Seligman SJ
    J Infect Dis; 1973 Nov; 128():Suppl:543-4 p. PubMed ID: 4491133
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative in vitro activity of coumermycin against methicillin-resistant Staphylococcus aureus.
    Meyers BR; Srulevitch ES; Hirschman SZ
    Antimicrob Agents Chemother; 1985 Nov; 28(5):706-7. PubMed ID: 3853964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.
    Claeys KC; Smith JR; Casapao AM; Mynatt RP; Avery L; Shroff A; Yamamura D; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1969-76. PubMed ID: 25605354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Alvarez S; Jones M; Berk SL
    Antimicrob Agents Chemother; 1985 Nov; 28(5):689-90. PubMed ID: 3853963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
    Memikoğlu KO; Bayar B; Kurt O; Cokça F
    Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole activity and pharmacodynamics against glycopeptide-intermediate Staphylococcus aureus.
    Close SJ; McBurney CR; Garvin CG; Chen DC; Martin SJ
    Pharmacotherapy; 2002 Aug; 22(8):983-9. PubMed ID: 12173801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New applications of old antimicrobials.
    Marks MI
    Pediatr Ann; 1986 Jun; 15(6):434-5, 438-40. PubMed ID: 3523401
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981.
    Markowitz N; Pohlod DJ; Saravolatz LD; Quinn EL
    Antimicrob Agents Chemother; 1983 Mar; 23(3):450-7. PubMed ID: 6552151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.